Startups channel feed – Endpoints News

Startups channel feed

Metsera outlines $250M IPO plans as obesity biotech competition rises

3 months ago

Maze looks to lead IPO queue with $113M Nasdaq debut

3 months ago

UK biotech launches with T cell therapy technology to treat solid tumors

3 months ago

With Sam Altman’s help, Retro Biosciences eyes $1B to extend lifespan by 10 years

3 months ago

Obesity biotech Aardvark files for IPO to advance oral, hunger-suppressing drug

3 months ago

Oncology biotech ArriVent does another China ADC deal, this time with Lepu Biopharma

3 months ago

Sionna and Odyssey end JPM week with IPO filings

3 months ago

Another US biotech emerges with drug candidate from China-based Keymed

3 months ago

Exclusive: Day after GSK buyout, IDRx chair takes new investing role at Curie.Bio

3 months ago

Normunity nabs $75M Series B to advance T cell engager and launch first trial

3 months ago

Lilly to acquire cancer biotech Scorpion, which shares a co-founder with Loxo

3 months ago

Chasing the next wave of obesity drugs, Metsera files for an IPO

3 months ago

Exclusive: Moderna's former top scientist has a new startup using AI to improve mRNA therapies

3 months ago

Another biotech scoops up asset from China-based Keymed and nabs $180M

3 months ago

Lilly ventures into pulmonary fibrosis with startup Mediar

3 months ago

With $120M, GSK-allied Ouro Medicines throws its hat into burgeoning TCE ring

3 months ago

Intellia to cut workforce by 27%, plans commercialization of first CRISPR therapy in 2027

3 months ago

Versant unveils Light Horse with $62M and a partnership with Novartis

3 months ago

Leyden Labs gets $70M to test if nasal sprays can help protect against viruses

3 months ago

Coave raises €32M Series A despite being two years away from the clinic

4 months ago

Aiolos team reunites with $411M for new biotech with obesity drugs from China

4 months ago

Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic

4 months ago

Solid Bio's former CEO launches new rare disease startup with €65M Series A

4 months ago

Roche's Chugai partners with Swiss ADC biotech Araris

4 months ago

First page Previous page 2 3 456 7 8 Next page Last page